Median PFS for erlotinib versus docetaxel was @ v @ months ( hazard ratio -LSB- HR -RSB- , @ ; @ % CI , @ to @ ; P = @ ) , and median OS was @ v @ months ( HR , @ ; @ % CI , @ to @ ; P = @ ) , respectively .